Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Sleep Apnea, Central

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Sleep Apnea, Central in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Sleep Apnea, Central: A condition associated with multiple episodes of sleep apnea which are distinguished from obstructive sleep apnea (SLEEP APNEA, OBSTRUCTIVE) by the complete cessation of efforts to breathe. This disorder is associated with dysfunction of central nervous system centers that regulate respiration.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stettner, GM1
Zanella, S1
Hilaire, G1
Dutschmann, M1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Sleep Apnea, Central

ArticleYear
8-OH-DPAT suppresses spontaneous central apneas in the C57BL/6J mouse strain.
    Respiratory physiology & neurobiology, 2008, Mar-20, Volume: 161, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Mice; Mice, Inbred C57BL; Plethysmography, Whole Bo

2008